| Authors: |
Yong K; aDepartment of Haematology, Cancer Institute, University College London, London, UK., Martin T; bDepartment of Hematology, University of California at San Francisco, San Francisco, CA, USA., Dimopoulos MA; cThe National and Kapodistrian University of Athens, Athens, Greece., Mikhael J; dTranslational Genomics Research Institute, City of Hope Cancer Center, Phoenix, AZ, USA., Capra M; eCentro Integrado de Hematologia e Oncologia, Hospital Mãe de Deus, Porto Alegre, Brazil., Facon T; fDepartment of Haematology, Lille University Hospital, Lille, France., Hajek R; gDepartment of Hemato-Oncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Špička I; hDepartment of Hematology, First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic., Baker R; iPerth Blood Institute, Murdoch University, Perth, Australia., Kim K; jDivision of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Martinez G; kHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Min CK; lDepartment of Hematology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea., Pour L; mDepartment of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic., Leleu X; nService d'Hématologie et Thérapie Cellulaire, CHU and CIC Inserm 1402, Poitiers Cedex, France., Oriol A; oInstitut Josep Carreras and Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Badalona, Spain., Koh Y; pDepartment of Internal Medicine, Seoul National University Hospital, Seoul, South Korea., Suzuki K; qMyeloma/Amyloidosis Center, Japanese Red Cross Medical Center, Tokyo, Japan., Casca F; rIvidata Life Science, Levallois-Perret, France., Macé S; sSanofi, R&D, Chilly-Mazarin, France., Moreau P; tDepartment of Hematology, University Hospital Hôtel-Dieu, Nantes, France. |
